¿Quiénes somos? ¿Dónde estamos? Contacta ¿Qué es la MBE? Aviso Legal
 
Búsqueda Bibliográfica El Estudio Comentarios Cat
Completo
Menu Documentos MBE
Versión en Pdf Imprimir Cat Su opinión es muy importante
Documentos MBE/ Revisiones Sistemáticas/Metaanálisis  
TRATAMIENTO CON ANTILEUCOTRIENOS Y CHURG-STRAUSS EN PACIENTES CON ASMA. revisión SISTEMÁTICA

El tratamiento con antileucotrienos en pacientes con asma, puede favorecer el desarrollo del síndrome de Churg-Strauss.

Pregunta:
¿El tratamiento con antileucotrienos, en pacientes con asma, tiene una relación causal con el desarrollo de síndrome de Churg-Strauss?

Búsqueda Bibliográfica  
Más
  • 1. New England Journal Med
  • 2. Annals of Internal Medicine
  • 3. Achives of Internal Medicine
  • 4. American Journal of Medicine
  • 5. Mayo Clinic Proceedings
  • 6. Medicine (Baltimore)
  • 7. JAMA
  • 8. Lancet
  • 9. British Medical Journal
  • 10. Medicina Clínica
  • 11. Revista Clínica Española
  • 12. Archivos Bronconeumología
  • 13. American Journal Respiratory and Critical Care Medicine
  • 14. Thorax
  • 15. Chest
  • 16. European Respiratory Journal
  • 17. Respiration
  • 18. Respiratory Medicine
  • 19. Lung
  • 20. Radiology
  • 21. American Journal Roentgenology
  • 22. Journal Thoracic and Cardiovascular Surgery
  • 23. Annals Thoracic Surgery
  • 24. Lung Cancer
  • 25. Respirology
  • 26. Cancer
  • 27. Journal of Thoracic Oncology
  • 28. Journal Thoracic Imagen
  • 29. Seminars in Respiratory and Critical Care Medicine
  • 30. Respiratory Physiology
Menos
Documentos Preseleccionados  
Más

Puéchal X, Rivereau P, Vinchon F. Churg-Strauss syndrome associated with omalizumab. Eur J Intern Med. 2008 Jul;19(5):364-6.

Nathani N, Little MA, Kunst H, Wilson D, Thickett DR. Churg-Strauss syndrome and leukotriene antagonist use: a respiratory perspective. Thorax. 2008 Oct;63(10):883-8.

McDanel DL, Muller BA. The linkage between Churg-Strauss syndrome and leukotriene receptor antagonists: fact or fiction? Ther Clin Risk Manag. 2005 Jun;1(2):125-40.

Hauser T, Mahr A, Metzler C, Coste J, Sommerstein R, Gross WL, Guillevin L, Hellmich B. The leucotriene receptor antagonist montelukast and the risk of Churg-Strauss syndrome: a case-crossover study. Thorax. 2008 Aug;63(8):677-82.

Zandman-Goddard G, Sylantiev C, Langevitz P. Montelukast-related Churg-Strauss vasculitis presenting with peripheral neuropathy. Isr Med Assoc J. 2007 Jan;9(1):50-1.

Cuchacovich R, Justiniano M, Espinoza LR. Churg-Strauss syndrome associated with leukotriene receptor antagonists (LTRA). Clin Rheumatol. 2007 Oct;26(10):1769-71.

Harrold LR, Patterson MK, Andrade SE, Dube T, Go AS, Buist AS, Chan KA, Weller PF, Wechsler ME, Yood RA, Davis KJ, Platt R, Walker AM. Asthma drug use and the development of Churg-Strauss syndrome (CSS). Pharmacoepidemiol Drug Saf. 2007 Jun;16(6):620-6.

Ng J, Savage R, McQueen F. Churg-Strauss vasculitis syndrome and leukotriene receptor antagonists. Ann Rheum Dis. 2005 Sep;64(9):1382.

Shimbo J, Onodera O, Tanaka K, Tsuji S. Churg-Strauss syndrome and the leukotriene receptor antagonist pranlukast. Clin Rheumatol. 2005 Nov;24(6):661-2.

Conen D, Leuppi J, Bubendorf L, Ronsdorf A, Tamm M, Hauser T. Montelukast and Churg-Strauss syndrome. Swiss Med Wkly. 2004 Jun 26;134(25-26):377-80.

Oberndorfer S, Beate U, Sabine U, Peter H, Heinz L, Barabra H, Wolfgang G. Churg Strauss syndrome during treatment of bronchial asthma with a leucotriene receptor antagonist presenting with polyneuropathy. Neurologia. 2004 Apr;19(3):134-8.

Boccagni C, Tesser F, Mittino D, Terazzi E, Naldi P, Colombi S, Zoppis E, Monaco F. Churg-Strauss syndrome associated with the leukotriene antagonist montelukast. Neurol Sci. 2004 Apr;25(1):21-2.

Kobayashi S, Ishizuka S, Tamura N, Takaya M, Kaneda K, Hashimoto H. Churg-Strauss syndrome (CSS) in a patient receiving pranlukast. Clin Rheumatol. 2003 Dec;22(6):491-2.

Keogh KA, Specks U. Churg-Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists. Am J Med. 2003 Sep;115(4):284-90.

Katsura T, Yoshida F, Takinishi Y. The Churg-Strauss syndrome after pranlukast treatment in a patient not receiving corticosteroids. Ann Intern Med. 2003 Sep 2;139(5 Pt 1):386-7.

Turvey SE, Vargas SO, Phipatanakul W. Churg-Strauss syndrome in a 7-year-old receiving montelukast and inhaled corticosteroids. Ann Allergy Asthma Immunol. 2003 Feb;90(2):274.

Gal AA, Morris RJ, Pine JR, Spraker MK. Cutaneous lesions of Churg-Strauss syndrome associated with montelukast therapy. Br J Dermatol. 2002 Sep;147(3):618-9.

Soy M, Ozer H, Canataroglu A, Gumurdulu D, Erken E. Vasculitis induced by zafirlukast therapy. Clin Rheumatol. 2002 Aug;21(4):328-9.

Pérez de Llano LA, Veres Racamonde A, Parra Arrondo A. [Churg-Strauss syndrome in an asthmatic man treated with montelukast: continuedcontroversy]. Arch Bronconeumol. 2002 May;38(5):251. Spanish.

Guilpain P, Viallard JF, Lagarde P, Cohen P, Kambouchner M, Pellegrin JL, Guillevin L. Churg-Strauss syndrome in two patients receiving montelukast. Rheumatology (Oxford). 2002 May;41(5):535-9.

Hammer HB, Aukrust P, Frøland SS. [Churg-Strauss syndrome after treatment with Singulair (montelukast)] Tidsskr Nor Laegeforen. 2002 Feb 20;122(5):484-6. Norwegian.

Loughlin JE, Cole JA, Rothman KJ, Johnson ES. Prevalence of serious eosinophilia and incidence of Churg-Strauss syndrome in a cohort of asthma patients. Ann Allergy Asthma Immunol. 2002 Mar;88(3):319-25.

Solans R, Bosch JA, Selva A, Orriols R, Vilardell M. Montelukast and Churg-Strauss syndrome. Thorax. 2002 Feb;57(2):183-5.

McAuley DF, McGovern V, Dick PT, Lawson JT, MacMahon J. Churg-Strauss syndrome associated with leukotriene receptor antagonists. Ulster Med J. 2001 Nov;70(2):152-4. No abstract available.

Weller PF, Plaut M, Taggart V, Trontell A. The relationship of asthma therapy and Churg-Strauss syndrome: NIH workshop summary report. J Allergy Clin Immunol. 2001 Aug;108(2):175-83.

Hashimoto M, Fujishima T, Tanaka H, Kon H, Saikai T, Suzuki A, Nakatsugawa M, Abe S. Churg-Strauss syndrome after reduction of inhaled corticosteroid in a patient treated with pranlukast for asthma. Intern Med. 2001 May;40(5):432-4.

Hosker HS, Tuggey JM. Montelukast and Churg-Strauss syndrome. Thorax. 2001 Mar;56(3):244.

Trujillo-Santos AJ, Peralta-Camisuli L, García de Lucas MD, García-Alegría J. [Churg-Strauss syndrome associated with montelukast] Med Clin (Barc). 2000 Nov 4;115(15):599.

Tuggey JM, Hosker HS. Churg-Strauss syndrome associated with montelukast therapy. Thorax. 2000 Sep;55(9):805-6.

Baba K, Niwa S, Yagi T, Sakakibara A, Kobayashi T, Matsumoto Y. [Churg-Strauss syndrome during corticosteroid tapering in a patient with bronchial asthma receiving pranlukast] Arerugi. 2000 Jun;49(6):512-5. Japanese.

Villena V, Hidalgo R, Sotelo MT, Martin-Escribano P. Montelukast and Churg-Strauss syndrome. Eur Respir J. 2000 Mar;15(3):626.

Wechsler ME, Finn D, Gunawardena D, Westlake R, Barker A, Haranath SP, Pauwels RA, Kips JC, Drazen JM. Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma. Chest. 2000 Mar;117(3):708-13.
Menos
Artículo Seleccionado  


Churg-Strauss syndrome and leukotriene antagonist use: a respiratory perspective. Nathani N, Little MA, Kunst H, Wilson D, Thickett DR. Thorax. 2008 Oct;63(10):883-8.

Más
Razones para la selección del artículo:: Es la única revisión sistemática que aborda el tema de la pregunta.
Menos
 
Menu Web
Patrocinadores:
Inicio Volver Arriba Establecer como Página de Inicio Atrás Añadir a mis favoritos
Mejor idea de la década. Diario Médico
Grupo de Medicina Basada en la Evidencia. Servicio de Neumología. Hospital Universitario 12 de Octubre
Grupo de Medicina Basada en la Evidencia
Hospital Universitario 12 de Octubre

Desarrollado por:
Quodem Consultores

Última modificación: 01/04/2014